Fluorescence in situ hybridization determination of aneusomy: Criteria and technical considerations

Analytical and Quantitative Cytology and Histology

Volumn 29, Issue 6, 2007, Pages 351-357

  Chadwick, Barbara ^a   Willmore Payne, Carlynn ^a   Holden, Joseph ^a   Layfield, Lester ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Aneusomy; Disomy; Fluorescence in situ hybridization; Polysomy

Indexed keywords

KI 67 ANTIGEN;

ANEUSOMY; ANTIGEN EXPRESSION; ARTICLE; BRAIN TISSUE; CELL PROLIFERATION; CHROMOSOME 13; CHROMOSOME 7; CHROMOSOME ANALYSIS; CHROMOSOME NUMBER; CONTROLLED STUDY; DIPLOIDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TRISOMY 7;

ANEUPLOIDY; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CELL LINE; CELL PROLIFERATION; CENTROMERE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 7; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; TRISOMY;

EID: 37349077918     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Botti C, Pescatore B, Mottolese M, Sciarretta F, Greco C, Di Filippo F, Gandolfo GM, Cavaliere F, Bovani R, Varanese A, Cianciulli AM: Incidence of chromosome 1 and 17 aneusomy in breast cancer and adjacent tissue: An interphase cytogenetic study. J Am Coll Surg 2000;190:530-539
2. Wang S, Hossein Saboorian M, Frenkel EP, Haley BB, Siddiqui MT, Gokaslan S, Hynan L, Ashfaq R: Aneusomy 17 in breast cancer: Its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status. Mod Pathol 2002;15:137-145
3. Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A, Tonato M, Franklin WA, Crino L, Bunn PA, Varella-Garcia M: Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst 2005;97:643-655
4. Wada Y, Igawa M, Shiina H, Shigeno K, Yokogi H, Urakami S, Yoneda T, Maruyama R: Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki-67 expression in renal cell carcinoma. Br J Cancer 1998;77:2003-2007
5. Cappuzzo F, Varella-Garcia M, Shigematsu H, Domenichini I, Bartolini S, Ceresoli GL, Rossi E, Ludovini V, Gregorc V, Toschi L, Franklin WA, Crino L, Gazdar AF, Bunn PA, Hirsch FR: Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients. J Clin Oncol 2005;23:5007-5018
6. Merola R, Mottolese M, Orlandi G, Vico E, Cognetti F, Sperduti I, Fabi A, Vitelli G, Ciancialli AM: Analysis of aneusomy level, Her-2 gene copy number analyzed by fluorescence in-situ hybridization and their effect on amplification rate in breast cancer specimens read as 2+ immunohistochemical analysis. Eur J Cancer 2006;42:501-506
7. Mezzelani A, Alasio L, Bartoli C, Bonora MG, Pierotti MA, Rilke F, Pilotti S: c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates. Br J Cancer 1999;80:519-525
8. Kapranos N, Kounelis S, Karantasis H, Kouri E: Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer. Breast J 2005;11:448-453
9. Salido M, Tusquets I, Corominas JM, Suarez M, Espinet B, Corzo C, Bellet M, Fabregat X, Serrano S, Solé F: Polysomy of chromosome 17 in breast cancer tumors showing an over-expression of ERBB2: A study of 175 cases using fluorescence in situ hybridization and immunohistochemistry. Breast Cancer Res 2005;7:R267-R273
10. Aubele M, Zitzelsberger H, Szücs S, Werner M, Braselmann H, Hutzler P, Rodenacker K, Lehmann L, Minkus G, Höfler H: Comparative FISH analysis of numerical chromosome 7 abnormalities in 5-micron and 15-micron paraffin-embedded tissue sections from prostatic carcinoma. Histochem Cell Biol 1997;107:121-126